Antonious Hazim

Hematology | Oncology
5881 E Mayo Blvd
Phoenix, AZ 85054

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

Cellular Therapies in Solid Tumors: Are We Ready for Primetime?

Journal: JCO oncology practice
Published: May 20, 2026

Study of the Perceptions and Concerns of a Single Health System Hematology and Oncology Workforce About Artificial Intelligence in Clinical Practice and Medical Education.

Study of the Perceptions and Concerns of a Single Health System Hematology and Oncology Workforce About Artificial Intelligence in Clinical Practice and Medical Education.

Journal: JCO clinical cancer informatics
Published: March 30, 2026

Neoadjuvant Chemoimmunotherapy in Resectable NSCLC With PD-L1 Expression < 1%: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Neoadjuvant Chemoimmunotherapy in Resectable NSCLC With PD-L1 Expression < 1%: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.

Journal: Clinical lung cancer
Published: January 07, 2026

Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer.

Evolving Field of Immunotherapy: Pioneering New Paths in Small-Cell Lung Cancer.

Journal: JCO oncology practice
Published: February 03, 2025

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Diversity of BRAF mutations in non-small cell lung cancer and implications on treatment.

Journal: NPJ precision oncology
Published: June 23, 2024

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.

Clinical characteristics, outcomes, and predictive modeling of patients diagnosed with immune checkpoint inhibitor therapy-related pneumonitis.

Journal: Cancer immunology, immunotherapy : CII
Published: June 19, 2024

Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.

Clinical characteristics, molecular aberrations, treatments, and outcomes of malignant histiocytosis.

Journal: American journal of hematology
Published: December 22, 2023

Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide.

Changes in vascular function and correlation with cardiotoxicity in women with newly diagnosed breast cancer undergoing HER2-directed therapy with and without anthracycline/cyclophosphamide.

Journal: European heart journal open
Published: August 22, 2023

Reply.

Reply.

Journal: Ophthalmology
Published: May 10, 2023

Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findings.

Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findings.

Journal: British journal of haematology
Published: June 06, 2022

Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.

Ophthalmologic Involvement in Adults with Histiocytic Disorders: Clinical Presentation and Treatment Outcomes.

Journal: Ophthalmology
Published: April 07, 2022

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 22, 2021
Showing 1-12 of 27

Last Updated: 09/26/2026